4.6 Article

Treatment of depression with low-strength transcranial pulsed electromagnetic fields: A mechanistic point of view

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.pnpbp.2016.07.006

关键词

Depression; MDD; Biological clock; Circadian rhythms; Cryptochrome; TMS; PEMF; tPEMF; Weak electromagnetic fields

资金

  1. UMCG Innovation Fund [U-11-221]
  2. Fonds NutsOhra [1103-068]

向作者/读者索取更多资源

Background: Mood disorders constitute a high burden for both patients and society. Notwithstanding the large arsenal of available treatment options, a considerable group of patients does not remit on current antidepressant treatment. There is an urgent need to develop alternative treatment strategies. Recently, low-strength transcranial pulsed electromagnetic field (tPEMF) stimulation has been purported as a promising strategy for such treatment-resistant depression (TRD). The mode of action of this new technique is however largely unknown. Methods: We searched PubMed for literature reports on the effects of tPEMF and for information regarding its working mechanism and biological substrate. Results: Most studies more or less connect with the major hypotheses of depression and concern the effects of tPEMF on brain metabolism, neuronal connectivity, brain plasticity, and the immune system. Relatively few-studies paid attention to the possible chronobiologic effects of electromagnetic fields. Limitations: We reviewed the literature of a new and still developing field. Some of the reports involved translational studies, which inevitably limits the reach of the conclusions. Conclusion: Weak magnetic fields influence divergent neurobiological processes. The antidepressant effect of tPEMF may be specifically attributable to its effects on local brain activity and connectivity. (C) 2016 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Psychology, Clinical

Prevalence of internalizing disorders, symptoms, and traits across age using advanced nonlinear models

Hanna M. van Loo, Lian Beijers, Martijn Wieling, Trynke R. de Jong, Robert A. Schoevers, Kenneth S. Kendler

Summary: This study investigates the impact of age and sex on the point prevalence of different mood and anxiety disorders, internalizing symptoms, and neuroticism. The findings suggest that the point prevalence of internalizing disorders is typically highest between the ages of 30 and 50, and women report more internalizing disorders than men. However, the relative difference between the sexes remains stable across age.

PSYCHOLOGICAL MEDICINE (2023)

Article Psychology, Clinical

Statistical power in clinical trials of interventions for mood, anxiety, and psychotic disorders

Ymkje Anna de Vries, Robert A. Schoevers, Julian P. T. Higgins, Marcus R. Munafo, Jojanneke A. Bastiaansen

Summary: Statistical power is generally low in trials of psychotherapy, pharmacotherapy, and complementary and alternative medicine for mood, anxiety, and psychotic disorders. Underpowered studies tend to produce larger effect sizes, indicating the presence of reporting bias. Increasing sample sizes and reducing bias are necessary to improve the reliability of published literature in this field.

PSYCHOLOGICAL MEDICINE (2023)

Article Anthropology

Discussing the unspoken: A qualitative analysis of online forum discussions on mental health problems in young Moroccan-Dutch migrants

Madelien H. van de Beek, Erwin Landman, Wim Veling, Robert A. Schoevers, Lian van der Krieke

Summary: Migrants and their offspring are more prone to mental disorders, and the social factors play a significant role in their mental health. Young Moroccan-Dutch people feel isolated and discriminated against in their social environment. They explain mental health problems using religious and medical explanations.

TRANSCULTURAL PSYCHIATRY (2023)

Article Clinical Neurology

Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life

Guy M. Goodwin, Scott T. Aaronson, Oscar Alvarez, Merve Atli, James C. Bennett, Megan Croal, Charles DeBattista, Boadie W. Dunlop, David Feifel, David J. Hellerstein, Muhammad Ishrat Husain, John R. Kelly, Molly R. Lennard-Jones, Rasmus W. Licht, Lindsey Marwood, Sunil Mistry, Tomas Palenicek, Ozlem Redjep, Dimitris Repantis, Robert A. Schoevers, Batya Septimus, Hollie J. Simmons, Jair C. Soares, Metten Somers, Susan C. Stansfield, Jessica R. Stuart, Hannah H. Tadley, Nisha K. Thiara, Joyce Tsai, Mourad Wahba, Sam Williams, Rachel I. Winzer, Allan H. Young, Matthew B. Young, Sid Zisook, Ekaterina Malievskaia

Summary: This study explores the efficacy of COMP360, a synthetic formulation of psilocybin, in treating treatment-resistant depression (TRD). Results show that a single dose of psilocybin at 25 mg and 10 mg can significantly improve symptoms of depression. This study expands on previous research on the use of psilocybin in treating TRD.

JOURNAL OF AFFECTIVE DISORDERS (2023)

Article Biochemistry & Molecular Biology

The Relationship between Insomnia and the Pathophysiology of Major Depressive Disorder: An Evaluation of a Broad Selection of Serum and Urine Biomarkers

Tina Drincic, Jens H. van Dalfsen, Jeanine Kamphuis, Mike C. Jentsch, Sjoerd M. van Belkum, Marcus J. M. Meddens, Brenda W. J. H. Penninx, Robert A. Schoevers

Summary: Insomnia has a clinically relevant relationship with major depressive disorder (MDD), as it is associated with neurobiological alterations similar to the pathophysiology of MDD. This study aimed to investigate the relationship between insomnia and the main mechanisms of MDD in a clinical sample of MDD individuals.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Psychology, Clinical

Antiviral treatment in schizophrenia: a randomized pilot PET study on the effects of valaciclovir on neuroinflammation

Iris Jonker, Janine Doorduin, Henderikus Knegtering, Erna Van't Hag, Rudi A. Dierckx, Erik F. J. de Vries, Robert A. Schoevers, Hans C. Klein

Summary: This study aimed to determine whether add-on treatment of schizophrenic patients with the anti-viral drug valaciclovir would reduce hippocampal neuroinflammation and improve cognitive symptoms. Results showed that valaciclovir treatment reduced neuroinflammation in multiple brain regions, but had no effect on psychotic symptoms or cognitive functioning.

PSYCHOLOGICAL MEDICINE (2023)

Article Psychology, Clinical

A network analysis of depressive symptoms and metabolomics

Arja O. O. Rydin, Yuri Milaneschi, Rick Quax, Jie Li, Jos A. A. Bosch, Robert A. A. Schoevers, Erik J. J. Giltay, Brenda W. J. H. Penninx, Femke Lamers

Summary: Depression is associated with metabolic alterations, and the associations may vary across individual symptoms. Using a network perspective, this study found 28 associations between depressive symptoms and metabolites, with fatigue and hypersomnia symptoms consistently related to cholesterol and fatty acid measures.

PSYCHOLOGICAL MEDICINE (2023)

Correction Neurosciences

Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review (vol 239, pg 15, 2022)

Nina Schimmers, Joost J. Breeksema, Sanne Y. Smith-Apeldoorn, Jolien Veraart, Wim van den Brink, Robert A. Schoevers

PSYCHOPHARMACOLOGY (2023)

Article Psychiatry

Metabolomics signatures of depression: the role of symptom profiles

Hilde de Kluiver, Rick Jansen, Brenda W. J. H. Penninx, Erik J. J. Giltay, Robert A. A. Schoevers, Yuri Milaneschi

Summary: Depression overlaps with cardiometabolic conditions in terms of metabolomic signature. The metabolomic signature is linked to atypical depression profiles characterized by energy alterations. This specific clustering of metabolomic signature with clinical profile identifies a subgroup of depressed patients at higher cardiometabolic risk, potentially serving as a valuable target for interventions to reduce the detrimental impact of depression on health.

TRANSLATIONAL PSYCHIATRY (2023)

Article Multidisciplinary Sciences

Integrating personalized experience sampling in psychotherapy: A case illustration of the Therap-i module

Lino von Klipstein, Michelle N. Servaas, Robert A. Schoevers, Date C. van der Veen, Harriette Riese

Summary: This article presents a case study of integrating personalized experience sampling methodology (ESM) assessment and feedback into psychotherapy for depression. Through ESM questionnaires and feedback sessions, the patient and therapist collaboratively explore and analyze the patient's symptoms and concerns, finding the ESM module to be useful and insightful for treatment.

HELIYON (2023)

Article Multidisciplinary Sciences

Repeated oral esketamine in patients with treatment resistant depression and comorbid posttraumatic stress disorder

J. K. E. Veraart, M. van Westenbrugge, J. E. van Wulfften Palthe, A. van der Meij, R. A. Schoevers, J. de Jong

Summary: Ketamine and esketamine have shown potential as pharmacotherapeutic options for treatment resistant depression and other psychiatric disorders. This study explores the effects of repeated oral esketamine treatment in patients with TRD and comorbid PTSD. The results suggest that combining (es)ketamine treatment with psychotherapy may be promising for these patients.

HELIYON (2023)

Article Psychiatry

A blended module (STAIRS) to promote functional and personal recovery in patients with a major depressive disorder in remission: study protocol of a concurrent mixed methods randomized controlled trial

David Wedema, Klaas J. Wardenaar, Manna A. Alma, Antoinette D. I. van Asselt, Eliza L. Korevaar, Robert A. Schoevers

Summary: This article introduces a recovery program called STAIRS for patients with major depressive disorder (MDD) and plans to conduct a study to assess the program's efficacy, patients' subjective experiences, and cost-effectiveness.

BMC PSYCHIATRY (2023)

Article Oncology

Depression, anxiety, and the risk of cancer: An individual participant data meta-analysis

Lonneke A. van Tuijl, Maartje Basten, Kuan-Yu Pan, Roel Vermeulen, Luetzen Portengen, Alexander de Graeff, Joost Dekker, Mirjam I. Geerlings, Adriaan Hoogendoorn, Femke Lamers, Adri C. Voogd, Jessica Abell, Philip Awadalla, Aartjan T. F. Beekman, Ottar Bjerkeset, Andy Boyd, Yunsong Cui, Philipp Frank, Henrike Galenkamp, Bert Garssen, Sean Hellingman, Martijn Huisman, Anke Huss, Trynke R. de Jong, Melanie R. Keats, Almar A. L. Kok, Steinar Krokstad, Flora E. van Leeuwen, Annemarie I. Luik, Nolwenn Noisel, N. Charlotte Onland-Moret, Yves Payette, Brenda W. J. H. Penninx, Ina Rissanen, Annelieke M. Roest, Rikje Ruiter, Robert A. Schoevers, David Soave, Mandy Spaan, Andrew Steptoe, Karien Stronks, Erik R. Sund, Ellen Sweeney, Emma L. Twait, Alison Teyhan, W. M. Monique Verschuren, Kimberly D. van der Willik, Judith G. M. Rosmalen, Adelita V. Ranchor

Summary: A meta-analysis of individual participant data from 18 cohorts found no associations between depression or anxiety and most types of cancer, except for lung cancer and smoking-related cancers. The associations with lung and smoking-related cancers were attenuated when adjusting for known risk factors.

CANCER (2023)

Article Clinical Neurology

Increased affective reactivity among depressed individuals can be explained by floor effects: An experience sampling study

Lino von Klipstein, Michelle N. Servaas, Femke Lamers, Robert A. Schoevers, Klaas J. Wardenaar, Harriette Riese

Summary: Experience sampling studies show that depressed individuals react more strongly to positive and negative stimuli than non-depressed individuals, particularly on negative affect. However, these findings may be influenced by floor/ceiling effects and assumption violations. Using data from 346 participants, it was found that depressed individuals showed increased positive affect reactivity when accounting for assumption violations, but no evidence of increased negative affect reactivity. The results highlight the importance of considering modeling choices in affective reactivity studies.

JOURNAL OF AFFECTIVE DISORDERS (2023)

Article Clinical Neurology

Associations of maternal prenatal psychological symptoms and saliva cortisol with neonatal meconium microbiota: A cross-sectional study

Nadia Deflorin, Ulrike Ehlert, Rita T. Amiel Castro

Summary: Changes in the gut microbiome of infants have been associated with maternal psychological symptoms during pregnancy. This study found that maternal prenatal depressive symptoms are associated with lower diversity of the infant's microbiome, while maternal saliva cortisol levels are linked to increased diversity and changes in specific bacterial groups. Further research is needed to understand the implications of these microbiota alterations for child health.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2024)

Article Clinical Neurology

Association between suicidal behavior and impaired glucose metabolism in first-episode drug-naive patients with schizophrenia

Zheng Ma, Hui-Xia Zhou, Da-Chun Chen, Dong-Mei Wang, Xiang-Yang Zhang

Summary: The impaired glucose metabolism in drug-na & iuml;ve schizophrenia patients is strongly associated with suicidal behavior, suggesting that glucose metabolism abnormalities may be potential biomarkers of suicide in schizophrenia patients. Regular monitoring of glucose metabolism variables is essential for suicide prevention.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2024)

Article Clinical Neurology

Transdiagnostic cognitive biases in psychiatric disorders: A systematic review and network meta-analysis

Katie M. Lavigne, Jiaxuan Deng, Delphine Raucher-Chene, Adele Hotte-Meunier, Chloe Voyer, Lisa Sarraf, Martin Lepage, Genevieve Sauve

Summary: Psychiatric disorders are characterized by cognitive deficits and cognitive biases, which are associated with specific symptoms. While cognitive biases are present across diagnoses, their severity varies.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2024)

Article Clinical Neurology

Gamma oscillations in the mPFC: A potential predictive biomarker of depression and antidepressant effects

Yong-Yu Yin, Jiao-Zhao Yan, Shi-Xin Lai, Qian-Qian Wei, Si-Rui Sun, Li-Ming Zhang, Yun-Feng Li

Summary: This study found that gamma oscillations are closely associated with depression and may serve as predictive biomarkers of depression. Chronic restraint stress and lipopolysaccharide induced significant depression-like behaviors in mice and reduced gamma oscillations in the medial prefrontal cortex. Administration of ketamine, scopolamine, or fluoxetine increased gamma oscillations and exhibited rapid-acting antidepressant effects.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2024)

Article Clinical Neurology

Transcriptomic analyses of rats exposed to chronic mild stress: Modulation by chronic treatment with the antipsychotic drug lurasidone

Veronica Begni, Moira Marizzoni, Kerstin Camile Creutzberg, Diana Morena Silipo, Mariusz Papp, Annamaria Cattaneo, Marco Andrea Riva

Summary: Exposure to stressful experiences is a significant risk factor for mental disorders, and pharmacological interventions targeting stress-induced alterations can help restore brain function. Lurasidone, an antipsychotic drug, has been shown to normalize the impairments caused by stress exposure and could be a valuable treatment for stress-induced mental illnesses. However, the mechanisms underlying the therapeutic effects of lurasidone are not well understood. This study found that chronic lurasidone treatment counteracted some of the transcriptional changes induced by chronic mild stress exposure, providing new insights into the potential therapeutic effects of lurasidone.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2024)

Article Clinical Neurology

Early life interpersonal stress and depression: Social reward processing as a potential mediator

Esther E. Palacios-Barrios, Kunal Patel, Jamie L. Hanson

Summary: This review examines the association between early life interpersonal stress (ELIS) and depression, as well as the underlying mechanisms. The research shows that ELIS affects how youth respond to social rewards, and similar impairments in social reward processing are observed in youth with depression. The authors propose a preliminary model that suggests neurobehavioral disruptions in social reward processing as a mediating factor in the connection between ELIS and depression.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2024)

Article Clinical Neurology

Metabolomics and transcriptomics analysis of prefrontal cortex in the Pax2 neuron-specific deletion mice

Rui Li, Jiaming Tang, Yizhuo Wang, Ying Wang, Hua Yang, Hongen Wei

Summary: Restricted and repetitive behaviors (RRBs) are characteristic features of neuropsychiatric disorders. This study focused on repetitive self-grooming behavior and investigated the involvement of the Pax2 gene in its control. Through the use of Pax2 neuron-specific deletion mice, the study found that the deletion of Pax2 gene affects the expression of the Arc gene in the prefrontal cortex, leading to impaired synaptic plasticity and excitatory/inhibitory imbalance, thereby contributing to the occurrence of repetitive self-grooming behavior.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2024)

Article Clinical Neurology

Changes in neurotrophic signaling pathways in brain areas of the chronic mild stress rat model of depression as a signature of ketamine fast antidepressant response/non-response

Sara Derosa, Paulina Misztak, Jessica Mingardi, Giulia Mazzini, Heidi Kaastrup Muller, Laura Musazzi

Summary: This study investigated the involvement of neurotrophic signaling pathways in stress vulnerability/resilience and fast antidepressant response/non-response to ketamine in a rat model of depression. The findings showed that stress and ketamine induced specific changes in these pathways in different brain areas and subcellular fractions.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2024)

Review Clinical Neurology

To what extent does white matter map to cognition in bipolar disorder? A systematic review of the evidence

Georgia F. Caruana, Sean P. Carruthers, Michael Berk, Susan L. Rossell, Tamsyn E. Van Rheenen

Summary: Cognitive impairment is related to both white matter macrostructure and microstructure in bipolar disorder patients. However, there is inconsistency in the results of the studies examining this relationship. Some studies have found an association between higher fractional anisotropy in white matter and better complex attention skills and executive functioning in bipolar disorder patients, while others have found no associations. Further research with increased statistical power and standardized methods is needed.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2024)

Review Clinical Neurology

Effectiveness of rTMS and tDCS treatment for chronic TBI symptoms: A systematic review and meta-analysis

Alberto Galimberti, Martin Tik, Giovanni Pellegrino, Anna-Lisa Schuler

Summary: This study provides a systematic review and meta-analysis on the effectiveness of repetitive transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS) for post-traumatic brain injury (TBI) symptoms. The results show that non-invasive brain stimulation techniques have a small overall effect on TBI sequelae, with significant effects observed for anxiety and headache. However, larger randomized controlled trials with longer follow-ups, optimized stimulation parameters, and standardized methodology are needed to establish the efficacy of these techniques in addressing TBI sequelae.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2024)

Article Clinical Neurology

Doxycycline diminishes the rewarding and psychomotor effects induced by morphine and cocaine

Amanda J. Sales, Pedro H. Gobira, Joa F. C. Pedrazzi, Joao R. Silveia, Elaine Del Bel, Felipe V. Gomes, Francisco S. Guimaraes

Summary: The study found that doxycycline can inhibit metalloproteinase in the brain and attenuate the rewarding effects and locomotor sensitization of drug abuse. This suggests that doxycycline could be repurposed for the treatment of substance use disorders.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2024)

Article Clinical Neurology

An updated overview on the relationship between human gut microbiome dysbiosis and psychiatric and psychological disorders

Alejandro Borrego-Ruiz, Juan J. Borrego

Summary: There is substantial evidence that the development of the nervous system is related to the composition and functions of the gut microbiome. The communication between the central nervous system (CNS) and the gut microbiota is bidirectional, with various routes such as immune, endocrine, and neural circuits. Dysbiosis of the gut microbiota has been associated with neuropsychiatric diseases and psychological disorders. Fecal microbiota transplantation (FMT) therapy has shown a causal-effect relationship between the gut microbiota and behavioral features. Interventions based on prebiotics, probiotics, or synbiotics have demonstrated their influence on neurological disorders through the synthesis of neuroactive compounds and regulation of inflammatory and endocrine processes. Further research is needed to explore the impact of gut microbiota dysbiosis on psychiatric and psychological disorders and the potential therapeutic role of microbiota-based interventions.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2024)

Article Clinical Neurology

Associations of resilience, white matter topological organization, and cognitive functions in first-episode, drug-naive schizophrenia patients: A moderated mediation analysis

Zhinan Li, Zhuang Kang, Xiaowei Xia, Leijun Li, Junyan Wu, Jiamin Dai, Tong Liu, Cai Chen, Yong Qiu, Ming Chen, Yanxi Liu, Ziyi Zhang, Zili Han, Zhengjia Dai, Qinling Wei

Summary: This study found that patients with schizophrenia showed lower levels of resilience and cognitive functions compared to healthy controls, as well as abnormal global properties and nodal metrics in brain networks. Furthermore, characteristic path length might moderate the relationship between resilience and working memory in these patients.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2024)

Article Clinical Neurology

Executive functioning trajectories and their prospective association with inflammatory biomarkers in schizophrenia and non-psychiatric comparison participants

David H. Adamowicz, Tsung-Chin Wu, Rebecca Daly, Michael R. Irwin, Dilip Jeste, Xin M. Tu, Lisa T. Eyler, Ellen E. Lee

Summary: This study aimed to explore the relationship between executive functioning and inflammatory biomarkers in people with schizophrenia. The results showed that systemic inflammation did not predict long-term declines in executive functioning. This suggests the need for further research to better understand the relationship and mechanisms between inflammation and cognition in schizophrenia.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2024)

Article Clinical Neurology

A multivariate cognitive approach to predict social functioning in recent onset psychosis in response to computerized cognitive training

Nina Walter, Julian Wenzel, Shalaila S. Haas, Letizia Squarcina, Carolina Bonivento, Anne Ruef, Dominic Dwyer, Theresa Lichtenstein, Oeznur Bastruek, Alexandra Stainton, Linda A. Antonucci, Paolo Brambilla, Stephen J. Wood, Rachel Upthegrove, Stefan Borgwardt, Rebekka Lencer, Eva Meisenzahl, Raimo K. R. Salokangas, Christos Pantelis, Alessandro Bertolino, Nikolaos Koutsouleris, Joseph Kambeitz, Lana Kambeitz-Ilankovic

Summary: Clinical and neuroimaging data can be used to predict the potential of cognitive training to improve social functioning in recent onset psychosis patients. The use of multivariate pattern analysis and support vector machine classifier allows for the prediction of social functioning improvement based on baseline cognitive data. The findings suggest that cognitive data can provide a robust individual estimate of future social functioning for patients with recent onset psychosis.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2024)